Keywords: EMEA approval, Baxter, Celvapan, MEPs' safety concerns

EMEA backs Baxter’s swine flu jab Celvapan but MEPS debate safety

Article | 02 October 2009

Print This

The European Medicines Agency (EMEA) has recommended to the European Commission that an additional vaccine against influenza A(H1N1), ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in